Child neurologist, dentist, or dermatologist. Doctors with unrelated specialties also prescribe drugs like Ozempic
In Slovakia, the anti-obesity drug Ozempic and similar medications are increasingly prescribed by doctors across various specialties, not limited to endocrinology.
The Ozempic Tsunami is Rolling Over the Czechs and Moravians. Without a Change in Lifestyle, It's Just Wasted Money
The article discusses the impact of the popular weight-loss drug Ozempic in Czechia, emphasizing that without accompanying lifestyle changes, its effectiveness may be limited.
Paraguay announces retatrutida, but agency claims there is no authorization; drug is still in clinical study phase
A Paraguayan lab announced a drug for obesity treatment which lacks regulatory approval, as it is still in clinical trials despite promotional events.
Urupês releases weight-loss pen for residents with obesity in the municipal health network; understand the criteria
The city of Urupês in Brazil will start offering the drug tirzepatide, also known as Mounjaro, for free to residents suffering from obesity as part of a local health initiative.
Medications: How Well Does Each Weight Loss Drug Work?
The article discusses the recent advancements in weight loss medications available in Germany since 2023, emphasizing their effectiveness and potential to reduce related health conditions.
Novo Nordisk: Reducing drug prices for obesity and diabetes by 50% in the USA
Novo Nordisk has announced a 50% reduction in the prices of its obesity and diabetes medications in the USA, effective January 2027.
Novo Nordisk will halve the price of its anti-obesity drug Wegovy in the United States starting in 2027
Novo Nordisk announced a plan to reduce the price of its anti-obesity drug Wegovy by 50% in the U.S. starting in 2027 to improve affordability and competitiveness.
Novo Nordisk: 15% Drop in Stock - Why the Clinical Trial of CagriSema Was Disappointing
Novo Nordisk's stock plummeted 15% after its new drug CagriSema failed to meet key weight-loss targets in a clinical trial compared to Eli Lilly's tirzepatide.
Novo Nordisk sinks again on the stock market after failing trials for its new obesity drug
Novo Nordisk's shares dropped significantly after the company reported failures in trials for its experimental obesity drug, CagriSema.
New obesity drug dose approved: studies show up to 21 percent weight loss
A new 7.2 mg dose of an obesity medication has been approved, with studies indicating it can lead to significant weight loss in patients.
Problem with obesity drugs: patients lose too much weight, get scared, and stop taking them
A new obesity drug trial reveals significant weight loss but raises concerns as patients abandon the study due to fears of losing too much weight.
'I'm a doctor and I took Mounjaro, there are things you need to know'
A UK doctor shares his personal experience with the weight loss drug Mounjaro, detailing both physical and psychological effects during and after treatment.
New concerns about weight loss drugs: What happens if they work... too well?
Recent trials involving the weight loss drug retatrutide have raised concerns after participants reported significant weight loss, but also higher than normal dropout rates due to side effects.
New concerns about weight loss medications: What happens if they work too well?
Recent trials of a weight loss drug called retatrutide show significant weight loss, raising concerns among researchers about the potential for excessive weight loss and related side effects.
The hyped "wonder drug" may not necessarily lose a gram - A doctor explains what it's about
A new report highlights the ineffectiveness of certain obesity treatments, with insights from a leading doctor on the underlying reasons.
The 'Perfect Drug' from AI? A New Therapy for Obesity Could Upset the Market
A new AI-discovered therapy for obesity, ISM0676, presents potential advantages over existing GLP-1 receptor agonists, signifying a major shift in obesity treatment.
What are the side effects of Tirzepatide, the weight loss drug
Jorge Tartaglione discusses the newly introduced injectable drug Tirzepatide in Argentina, describing its use and potential side effects.
Nurse and husband arrested in the interior of SP with medication banned in Brazil
A nurse and her husband were arrested in MarÃlia, Brazil, for possessing an illegal medication intended for obesity and diabetes control.
Every medicine can work for knee osteoarthritis
An Australian study suggests that the diabetes drug metformin may alleviate knee osteoarthritis pain in overweight and obese individuals.
How the drugs that will revolutionize obesity treatment work
Semaglutide by Novo Nordisk is the first drug approved for obesity treatment that achieves weight loss comparable to bariatric surgery, while Eli Lilly's tirzepatide is expected to gain approval soon after showing efficacy and safety in clinical trials.
A generic Ozempic for 15 euros per month or how to revolutionize the obesity drug market
The expiration of Novo Nordisk's patent in some countries pressures the Danish pharmaceutical company as its diabetes injection Ozempic becomes synonymous with weight loss globally.
Novo Nordisk achieves a pyrrhic victory with Wegovy pills
Novo Nordisk's new oral obesity drug Wegovy offers only a minor advantage over Eli Lilly in the ongoing pharmaceutical battle for obesity treatments.
China’s weight-loss drug war: prices slashed up to 80% as obesity crisis worsens
China is experiencing a price war in the weight-loss drug market, with companies reducing prices by up to 80% in response to a worsening obesity crisis projected to affect over 630 million adults by 2050.
Polish diabetes and weight loss drug manufacturer Celon will employ 50 people in a new factory near Žilina
Polish pharmaceutical company Celon Pharma is set to establish a new factory in Žilina, creating 50 jobs and addressing the growing demand for diabetes and obesity medications.
Obesity drug ignites competition in America
Novo Nordisk has launched its oral weight loss drug 'Wegovy' in the US, leading to intensified competition in the obesity medication market.
Wegovy obesity pill now available at pharmacies
The Wegovy obesity pill has launched and is available at pharmacies nationwide, with higher doses expected by week's end.